A. Šimkaus klinika Therapia scientifica - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 17,921 | 18,012 | 13,225 | 9,844 | 12,067 | 23,126 | 56,222 | 61,768 |
| Profit before tax | 1,180 | 2,811 | 1,457 | -3,944 | -3,975 | 4,607 | 30,162 | 36,866 |
| Net profit | 1,180 | 2,811 | 1,457 | -3,944 | -3,975 | 4,607 | 29,828 | 35,652 |
| Equity | 15,092 | 17,903 | 19,360 | 15,416 | 11,441 | 16,048 | 45,877 | 81,529 |
| Liabilities | 378 | 330 | 472 | 525 | 873 | 1,809 | 2,186 | 2,949 |
| Non-current assets | 1,523 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 13,947 | 18,233 | 19,832 | 15,941 | 12,314 | 17,857 | 48,063 | 84,478 |
| Total assets | 15,470 | 18,233 | 19,832 | 15,941 | 12,314 | 17,857 | 48,063 | 84,478 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,931 | 497 | 1,104 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.9% | +0.5% | -26.6% | -25.6% | +22.6% | +91.6% | +143.1% | +9.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.6% | 15.4% | 7.3% | -24.7% | -32.3% | 25.8% | 62.1% | 42.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 7.8% | 15.7% | 7.5% | -25.6% | -34.7% | 28.7% | 65.0% | 43.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.6% | 15.6% | 11.0% | -40.1% | -32.9% | 19.9% | 53.1% | 57.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 6.6% | 15.6% | 11.0% | -40.1% | -32.9% | 19.9% | 53.6% | 59.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,961 | 9,006 | 6,613 | 4,922 | 6,034 | 11,563 | 28,111 | 30,884 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
A. Šimkaus klinika Therapia scientifica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-06 | 18.29 |
| 2026-08-26 | 2026-09-02 | 18.29 |
| 2026-08-23 | 2026-08-23 | 18.29 |
| 2026-08-19 | 2026-08-19 | 18.29 |
| 2026-07-23 | 2026-08-06 | 18.29 |
| 2026-07-19 | 2026-07-22 | 17.96 |
| 2026-07-16 | 2026-07-17 | 17.96 |
| 2026-06-16 | 2026-07-09 | 17.96 |
| 2026-05-17 | 2026-06-03 | 17.96 |
| 2026-05-03 | 2026-05-10 | 17.96 |
| 2026-04-20 | 2026-04-29 | 17.96 |
| 2022-12-23 | 2022-12-27 | 3.11 |
A. Šimkaus klinika Therapia scientifica - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Therapia scientifica, UAB (code 133763997) is a Private Limited Liability Company active in medical specialists activities. In 2025, the company generated EUR 61.8K in revenue, up 9.9% year on year and 167.1% over two years, showing a strong upward trajectory. Net profit reached EUR 35.7K, compared with EUR 29.8K in 2024 and EUR 4.6K in 2023, while the profit margin improved to 57.7% from 53.1% and 19.9% in the previous two years. The balance sheet remained solid, with total assets of EUR 84.5K, equity of EUR 81.5K and liabilities of EUR 2.9K at the end of 2025. The equity ratio was 96.5%, and debt to equity stood at 0.04, indicating very limited leverage. Return on equity was 43.7% and return on assets 42.2%, supported by efficient use of assets and a high margin structure. Asset turnover was 0.73x. Revenue per employee was EUR 30.9K and profit per employee EUR 17.8K, pointing to relatively strong productivity.